Optiscan Imaging Ltd has released a press release.
Appendix 4E and 2021 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
In the deck
Story so far
Earlier from Optiscan Imaging
- OIL June 2021 Quarterly Report and Appendix 4C
- Update on seeking United States FDA approval & market entry
- Appointment of new non-executive director
- OIL March 2021 Quarterly Report and Appendix 4C
- Appointment of new non-executive chair
Later from Optiscan Imaging
- OIL FY21 Annual Results Presentation
- Receipt of R&D Tax Incentive Rebate
- OIL September 2021 Quarterly Report and Appendix 4C
- Completion of imaging for Melbourne Breast cancer trial
- Change of Managing Director
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging